Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Serum-Derived Bovine Immunoglobulin in Children With Diarrhea-Predominant Irritable Bowel Syndrome

NCT02358694 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.

NCT NCT02358694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02358694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Serum-Derived Bovine Immunoglobulin in Children With Diarrhea-Predominant Irritable Bowel Syndrome
Lead sponsor
Connecticut Children's Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 15, 2014
Completion date
June 1, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea predominant irritable bowel syndrome